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Purpose/Objective: Ion beams due to superior dose profile 
over photons and electrons may provide higher dose-
conformity and healthy tissue sparing. But due to high costs 
and huge size ion beam therapy is limited to a few centers 
only. A novel ion acceleration process via ultra-intense laser-
matter interaction, promises size and cost reduction. 
However, laser-driven beams are characterized by intense 
particle bunches with peak dose rates exceeding 
conventional values by several orders of magnitude, low 
repetition rate, broad energy spread and large divergence, 
thus are diverse from conventional beams. This requires new 
solutions for developing Laser-based Ion Beam Therapy (LIBT) 
for clinical application. The presented work is a result of an 
ongoing joint translational research project of several 
institutions aiming to establish LIBT with protons and shows 
the status in five main challenges. 
Materials and Methods: I) Laser-based technology has been 
established, with protons (upto 20 MeV) via 150 TW laser 
system, for systematic radiobiological studies with human 
cell-lines and small animals with fixed beamline. 
II) For translation towards patient irradiation, increase of 
proton energy from 20 to 230 MeV by increasing the laser 
power from 150 TW to ~1 PW is required and in progress. 
III) Furthermore, a compact ion beam gantry system is 
designed based on pulsed magnets (PM), with integrated 
laser-particle acceleration chamber, novel beam capturing 
and energy selection system. A new pulsed scanning system 
for wide beams with broad energies is designed for 
irradiations with clinical accuracy. 
IV) The light-weight iron-less high-field PMs are being 
developed for gantry realization. These are non-trivial and 
extremely challenging to design.  
V) A new 3D TPS has been developed for new dose delivery 
and treatment planning strategies for LIBT.  
Results: No overall difference in the radiobiological 
effectiveness between laser-driven and conventional beams 
was detected to date. Therefore, a comparison of dose plans 
by treatment planning system is possible to evaluate the 
features of LIBT. The evaluation of treatment plans shows 
laser driven broad energetic beams are feasible for clinical 
application.  
Our double-achromatic 360° isocentric pulsed gantry design 
is ~2.5x smaller than conventional gantries (see fig.) and is 
capable of disperssionless scanning of high acceptance beams 
through 20x20 cm2 field size.  
For the realization, PMs have been designed and developed. 
A pulsed solenoid, for particle capturing and focusing, has 
been successfully tested at laser-driven beams. A novel 10 T 
compact pulsed 45° sector magnet has been developed and 
tested. Also, a pulsed high acceptance quadrupole with 250 
T/m gradient is being developed. 
 
 
 
Conclusions: LIBT is a promising compact alternative and 
could change IBT, yet requires substantial development 
towards clinical application.  
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Purpose/Objective: Radiation treatment planning with a 
commercial TPS is a trial and error process that often leads 
to sub-optimal organ sparing. We developed a method to 
predict feasible target and organ at risk (OAR) dose levels 
prior to the start of the treatment planning process. These 
predictions can be used (i) to guide the treatment planner to 
achieve optimal OAR sparing or target dose escalation; (ii) for 
quality assurance of the treatment planning process; (iii) to 
identify patients that may benefit from adaptive RT; (iv) to 
